Bupropion, Naltrexone

Contrave

90 MG + 8 MG Tablet (Extended-Release)CanadaMarketedAuthorised 16 Mar 2018

In other countries

The same active substances on other registers, the same brand first.

ContraveBrazil · Merck S/ASame brand
ContraveSaudi Arabia · Patheon INCSame brand
Contrave Prolonged Release Tablet 8MG/90MGSingapore · 90mg + 8.00mg · tablet, film coated, extended release · Inova Pharmaceuticals (Singapore) Pte. LimitedSame brand
ContraveUnited States · 90MG; 8MG · tablet, extended release · NalpropionSame brand
Mysimba 8 MG/90 MG Comprimidos de Liberacion ProlongadaSpain · 8 mg + 90 mg · comprimido de liberación prolongada · Orexigen Therapeutics Ireland LimitedSame form
MysimbaItaly · Compressa a rilascio prolungato · Orexigen Therapeutics Ireland LimitedSame form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Bupropion, Naltrexone

Contrave

90 MG + 8 MG Tablet (Extended-Release)CanadaMarketedAuthorised 16 Mar 2018

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Mysimba 8 mg/90 mg tabletten met verlengde afgifte

Netherlands · Tablet met verlengde afgifte · Orexigen Therapeutics Ireland Limited

Mysimba®Serbia · 90mg+8mg · tableta sa produženim oslobađanjem · Pharmaswiss D.O.O., Beograd

Naltrexone Hydrochloride; Bupropion HydrochlorideUnited States · 8MG/90MG · tablet, extended release · Actavis Labs FL INC

BupnalBrazil · Supera Farma Laboratórios S.A

cloridrato de bupropiona + cloridrato de naltrexonaBrazil · Eurofarma Laboratorios S.A.

MysimbaEuropean Union · Orexigen Therapeutics Ireland Limited

MysimbaCroatia

MYSIMBA 8 mg/90 mgRomania · 8mg/90mg · compr. elib. prel. · Orexigen Therapeutics Ireland Limited

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Bupropion, Naltrexone
Strength: 90 MG + 8 MG
Dosage form: Tablet (Extended-Release)
Route: Oral
Register: Canada (Health Canada)
Status: Marketed
Authorised: 16 Mar 2018
Registration: DIN 02472945
Marketing authorisation holder: Bausch Health, Canada INC.
ATC code: A08AA62
Group: Alimentary tract and metabolism
Supply: PRESCRIPTION